Ortho Clinical Diagnostics Holdings plc

Operating margin

8.5%

Net margin

−2.7%

Return on equity

−13.2%

Return on assets

−1.6%

Return on capital (ROCE)

6.2%

Liabilities / assets

87.8%

Debt / equity

7.19×

Book value / share

$1.73

Revenue growth (YoY)

15.7%

Net income growth (YoY)

—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Altman Z″ (distress)

-0.57distress

Accruals / assets

−10.1%clean

Beneish M-Score

-3.04normal

Piotroski F-Score

7/9strong

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

• Entered a material agreement · Terminated a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Regulation FD disclosure · Other material eventMay 27, 2022
• Director / officer changeMay 26, 2022
• Regulation FD disclosureMay 20, 2022
• Regulation FD disclosureMay 18, 2022
• Other material eventMay 16, 2022
• Other material eventMay 6, 2022
• Results of operationsMay 4, 2022
• Director / officer changeApr 7, 2022

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.